首页> 外文期刊>Clinical immunology: The official journal of the Clinical Immunology Society >Efficacy paradox and proportional contextual effect (PCE)
【24h】

Efficacy paradox and proportional contextual effect (PCE)

机译:疗效悖论和比例情境效应(PCE)

获取原文
获取原文并翻译 | 示例
           

摘要

The "efficacy paradox" is when the effect of a treatment tested in an RCT, or evidence-based guideline advice, differs markedly from treatment benefits observed in clinical practice. This arises because in RCT reporting and guideline development treatment efficacy is judged by the separation of the treatment group from the placebo group (the specific treatment effect) whereas in clinical practice it is the overall treatment effect, which includes both specific and contextual responses, that patients experience. This paradox causes a disconnect between guidelines and clinical practice and ignores the importance of contextual response in clinical care. This article fully explains and discusses these issues and presents a possible way to reduce the paradox through an alteration in RUT reporting that shifts the focus to overall treatment benefit and the proportion ("proportional contextual effect") that is explained by placebo and contextual effects. (C) 2017 Elsevier Inc. All rights reserved.
机译:“疗效悖论”是在RCT中测试的治疗或基于证据的准则建议的影响,与临床实践中观察到的治疗益处不同。这出现了因为在RCT报告和准则开发治疗中,通过将治疗组与安慰剂组(特定治疗效果)分离来判断疗效,而在临床实践中,这是整体治疗效果,包括具体和上下文的反应,即患者的经历。该悖论导致在指南和临床实践之间断开连接,并忽略临床护理中的语境反应的重要性。本文完全阐述并讨论了这些问题,并提出了通过RUT报告的改变来减少悖论的可能方法,使重点转移到整体治疗福利和安慰剂和语境效应解释的比例(“比例语境效应”)。 (c)2017年Elsevier Inc.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号